Januvia 100 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FJRWU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,345
Award facts
- Contract value 100% obligated
- $2,344.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,344.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Januvia 100 mg tablets (90-count units). This delivery order, issued on October 28, 2025, with an ultimate completion date of October 29, 2025, carries no set-aside designation, indicating the award was made through unrestricted competitive procurement. The order represents one of numerous delivery orders DMS Pharmaceutical Group has received from the Defense Logistics Agency's Medical Supply Chain division, reflecting the company's established capability as a federal pharmaceutical supplier.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC, awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor supporting the Department of Defense's military healthcare operations worldwide. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical consumable support to federal military medical facilities globally. DMS Pharmaceutical Group's performance across its diverse product portfolio—including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals—demonstrates its critical role within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FJRWU?
SPE2DB26FJRWU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FJRWU worth?
The government has obligated $2,345 on SPE2DB26FJRWU.
Is contract SPE2DB26FJRWU an order under another contract?
Yes. SPE2DB26FJRWU is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB26FJRWU competed?
The extent of competition for SPE2DB26FJRWU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award